Fundraising FoxIllimistx
Seoul, KR · 2 known investors
Find your way into Illimistx
Sign up to see every warm intro you have to Illimistx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Illimistx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Illimis Therapeutics is a biotech company developing therapeutics for intractable diseases, including GAIA-Aβ, a treatment aimed at improving Alzheimer's disease by clearing beta-amyloid via an efferocytosis-based mechanism that avoids the ARIA side effects of existing treatments. The company focuses on translating life science research into medicines for patients.
Founders & leadership
CK
Chanhyuk KimFounder
SP
Sanghoon ParkFounder
WC
Wonsuk ChungFounder
Investors · 2
Frequently asked questions
- What does Illimistx do?
- Illimis Therapeutics is a biotech company developing therapeutics for intractable diseases, including GAIA-Aβ, a treatment aimed at improving Alzheimer's disease by clearing beta-amyloid via an efferocytosis-based mechanism that avoids the ARIA side effects of existing treatments. The company focuses on translating life science research into medicines for patients.
- Who are Illimistx's investors?
- Illimistx's investors include Aju IB Investment, LB Investment.
- Where is Illimistx headquartered?
- Illimistx is headquartered in Seoul, KR.